Access Restriction

Author Udall, Don N.
Source CiteSeerX
Content type Text
File Format PDF
Language English
Subject Domain (in DDC) Computer science, information & general works ♦ Data processing & computer science
Description Recent progress in onchocerciasis research has led to improved understanding of the immunopathology of Onchocerca volvulus, as well as improvements in diagnosis and treatment of this morbid disease. This article reviews the recent literature, highlighting breakthroughs in sensitive means of antigen testing and an unusual new approach to therapy that targets an endosymbiotic bacterium required for filarial worm fecundity. EPIDEMIOLOGY Most widely known for causing “river blindness, ” Onch-ocerca volvulus infection affects an estimated 17.7 million people worldwide in 34 countries in Africa, the Middle East, South America, and Central America. An estimated 500,000 people and 270,000 people experience secondary visual impairment and blindness, respectively [1]. Nations with the highest historical prevalence of onch-ocerciasis include 11 sub-Saharan West African nations,
Inclusion in PubMed, CAS, Scopus and Google Scholar Research
Educational Role Student ♦ Teacher
Age Range above 22 year
Educational Use Research
Education Level UG and PG ♦ Career/Technical Study
Learning Resource Type Article